Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study von Xu, Dan, Yang, Ying, Yin, Zhao, Tu, Sanfang, Nie, Danian, Li, Yiqing, Huang, Zhenqian, Sun, Qixin, Huang, Changfen, Nie, Xiaqi, Yao, Zurong, Shi, Pengcheng, Zhang, Yu, Jiang, Xuejie, Liu, Qifa, Yu, Guopan

Volltext

The Efficacy and Safety of CLAG±Ida/Mito+Ven As Salvage Therapy of Relapsed/Refractory Acute Myeloid Leukemia von Yu, Guopan, Yin, Zhao, Zhang, Yu, Jiang, Xuejie, Nie, Xiaqi, Yao, Zurong, Xu, Dan, Shi, Pengcheng

Volltext

Homoharringtonine Enhances the Anti-Leukemia Effect of Venetoclax in Acute Myeloid Leukemia with t(8;21)(q22;q22) Via Regulation of c-Myc/Bim Axis von Yu, Guopan, Yin, Zhao, Yao, Zurong, Nie, Xiaqi, Jin, Hua, Zhang, Yu, Xu, Dan, Jiang, Xuejie, Ping, Baohong

Volltext

2006超级巨星会 von 赵守兵（采访） 聂蓉（采访） 杨帆 夏祺 沈峥妍 唐先才 徐安娜

Volltext